Globus Medical GMED
NYSE GMED
$73.92 -0.60 (-0.81%)
As of: Sep 10, 2026 · 2:24 PM EDT

Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026)

Globus Medical's (GMED) quarterly Total Non-Current Liabilities came in at $700.6 million in Q2 2026, up 8.9% on a YoY basis from $643.3 million in Q2 2025, and up 2.03% quarter-over-quarter from $686.7 million in Q1 2026.

Analysis

Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

Globus Medical (GMED) has reported Total Non-Current Liabilities for 16 consecutive years, with $700.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Non-Current Liabilities rose 8.9% year-over-year to $700.6 million; the trailing twelve-month figure through Jun 2026 stood at $700.6 million (up 8.9% YoY), and the FY2025 full-year result was $708.2 million, down 32.74% from the prior year.
  • Total Non-Current Liabilities advanced to $700.6 million in Q2 2026 per GMED's latest filing, from $686.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.1 billion in Q3 2023 and bottomed at $199.8 million in Q3 2022.
  • Historically, Total Non-Current Liabilities has averaged $639.7 million across 5 years, with a median of $679.2 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities jumped 473.67% in 2023, then plunged 40.11% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $219.4 million in 2022, then jumped by 384.73% to $1.1 billion in 2023, then fell by 1.0% to $1.1 billion in 2024, then sank by 32.74% to $708.2 million in 2025, then slipped by 1.07% to $700.6 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $700.6 million, $686.7 million, and $708.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 180.78 Bn 175.17 Bn 7.27 Bn -
2 Intuitive Surgical 127.04 Bn 121.82 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.04 Bn 108.22 Bn 6.34 Bn 40.46 Bn
4 Stryker 103.86 Bn 100.38 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 63.50 Bn 62.96 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.74 Bn 45.49 Bn 1.35 Bn 2.57 Bn
7 Alcon 32.99 Bn 31.53 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.12 Bn 30.17 Bn 830.00 Mn 3.68 Bn
9 Steris 20.69 Bn 20.21 Bn 684.20 Mn 3.44 Bn
10 Globus Medical 9.98 Bn 9.38 Bn 548.17 Mn 700.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 700.61 Mn
Mar 31, 2026 686.67 Mn
Dec 31, 2025 708.17 Mn
Sep 30, 2025 671.73 Mn
Jun 30, 2025 643.34 Mn
Mar 31, 2025 597.59 Mn
Dec 31, 2024 1.05 Bn
Sep 30, 2024 993.66 Mn
Jun 30, 2024 992.22 Mn
Mar 31, 2024 997.75 Mn
Dec 31, 2023 1.06 Bn
Sep 30, 2023 1.15 Bn
Jun 30, 2023 212.97 Mn
Mar 31, 2023 221.40 Mn
Dec 31, 2022 219.41 Mn
Sep 30, 2022 199.80 Mn
Jun 30, 2022 204.22 Mn
Mar 31, 2022 201.80 Mn
Dec 31, 2021 203.23 Mn
Sep 30, 2021 176.43 Mn